However, controversially, poor prognosis of cancer patients having a higher expression of SIRT6 has been reported in various human cancers, such as breast cancer [10], gastric cancer [19], lung cancer [20], osteosarcoma [21], and ovarian cancer [22]. Here, SIRT6 is linked to breast cancer.